A striking difference between the BCP-ALL subtypes is that the patients carrying the recurrent fusion genes ETV6-RUNX1, BCR-ABL or TCF3-PBX1 harbored exceptionally few mutations in known driver genes compared to the other BCP-ALL patients. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.